Melatonin is widely known as a sleep aid—and in oncology, it’s being studied for roles that extend well beyond sleep.
Over the past two decades, research has explored melatonin’s promising role in breast and gynecologic cancers, including its ability to support natural body defenses and notable interaction with tumor growth pathways [2,3].
Yet most people taking melatonin are focused on sleep—and often taking doses far beyond what the body naturally produces or needs.
DOSING: More Is Not Better
Melatonin is a hormone—not a sedative.
The body produces very small amounts naturally, and research suggests that physiologic blood levels are closer to 0.1–0.3 mg, achievable with far lower doses than the 5–10 mg amounts commonly found in supplements [4,5].
That doesn’t mean higher doses never have a place—such as when addressing jet lag—but when the goal is supporting natural sleep rhythms and cellular protection, research consistently points to 3 mg or less as a more appropriate long-term range [4,6].
At higher doses, people often experience:
- Grogginess the next morning
- Headaches
- Vivid dreams or disrupted sleep
There’s also an important potential risk with long-term use. While melatonin has not been shown to shut down natural production and long-term data is limited, researchers have raised concerns that consistent, high-dose use may affect how the body responds to its own melatonin signals, particularly circadian rhythm timing [6].
“Melatonin works best when it supports your rhythm—not when it overrides it.”
In simple terms: melatonin works best when it supports your rhythm—rather than overrides it—and the most effective approach is consistent use at lower doses.
FORM: Not All Melatonin Is the Same
Most people take immediate-release melatonin, which creates a quick spike in the bloodstream.
But that’s not how the body naturally produces melatonin.
Your body releases melatonin gradually over several hours during the night. That’s where sustained-release (SR) melatonin can make a difference.
- Immediate-release → helps you fall asleep
- Sustained-release (SR) → helps you stay asleep and better mimic natural physiology
The most effective formulations combine both approaches—immediate-release to help initiate sleep, and sustained-release (SR) to maintain it—which can be especially helpful for those waking in the middle of the night or dealing with fragmented sleep [7,8].
Additionally, where your melatonin is sourced matters.
The FDA and independent research have shown that some melatonin supplements—particularly gummies—can contain significantly different amounts than what’s listed on the label, and in some cases, additional unintended compounds [9].
For that reason, it’s important to choose products that are:
- Manufactured in cGMP-certified facilities
- Transparently labeled and preferably manufactured in the United States
- Produced in pill forms that allow for more consistent dosing
CANCER RESEARCH: Melatonin goes beyond sleep.
This is where melatonin becomes an ally to the body’s natural defense systems.
Notably, in breast and gynecologic cancers, melatonin has been studied for its effects on tumor-related pathways, particularly those involving estrogen signaling.
Laboratory research shows that melatonin can:
- Influence estrogen receptor activity and hormone signaling
- Reduce cellular proliferation in breast cancer models
- Act as an antioxidant, helping protect cells from oxidative stress [2,3]
Reviews also describe melatonin as a molecule with immune-modulating effects acting across multiple pathways involved in tumor development [2].
Population-based research has also been compelling. In a prospective study higher urinary melatonin levels were associated with a significantly lower risk of invasive breast cancer in postmenopausal women [1].
This makes melatonin a promising—but still evolving—area of oncology research.
The Bottom Line
Melatonin is simple—but it’s not simplistic.
- Dose matters (3 mg or less is a more appropriate long-term range)
- Form matters (SR vs. immediate-release changes how it works)
- And its role goes far beyond sleep
Used thoughtfully, melatonin can support the body’s natural sleep-wake rhythm—and its natural defenses.
But the goal isn’t to take more.
The goal is to take it consistently—and at proper dosing.
References
[1] Schernhammer ES, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.Journal of the National Cancer Institute.
https://pubmed.ncbi.nlm.nih.gov/18544743/
[2] González-González A, et al. Melatonin: A Molecule for Reducing Breast Cancer Risk. Molecules.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6017232/
[3] Grant SG, et al. Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. Expert Reviews in Molecular Medicine.
https://pubmed.ncbi.nlm.nih.gov/19193248/
[4] Arendt J. Physiology of the Pineal Gland and Melatonin. Endotext (NIH).
https://www.ncbi.nlm.nih.gov/books/NBK550972/
[5] Zhdanova IV, et al. Melatonin treatment for age-related insomnia.
https://pubmed.ncbi.nlm.nih.gov/11600532/
[6] Menczel Schrire Z, et al. Safety of higher doses of melatonin in adults: a systematic review.
https://pubmed.ncbi.nlm.nih.gov/34923676/
[7] Circadin (melatonin prolonged-release) EPAR – Scientific Discussion.
https://www.ema.europa.eu/en/documents/scientific-discussion/circadin-epar-scientific-discussion_en.pdf
[8] Wade AG, et al. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55+.
https://pubmed.ncbi.nlm.nih.gov/16090132/
[9] Cohen PA, et al. Quantity of Melatonin in Melatonin Gummies Sold in the United States. JAMA.
https://pubmed.ncbi.nlm.nih.gov/37222454/
